12/2
03:00 pm
evh
Evolent Health (NYSE:EVH) was given a new $6.00 price target on by analysts at Piper Sandler.
Low
Report
Evolent Health (NYSE:EVH) was given a new $6.00 price target on by analysts at Piper Sandler.
11/26
02:06 pm
evh
Evolent Health (NYSE:EVH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Evolent Health (NYSE:EVH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
03:23 pm
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $11.50 to $9.50. They now have a "buy" rating on the stock.
Low
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $11.50 to $9.50. They now have a "buy" rating on the stock.
11/20
01:47 am
evh
Evolent Health, American Oncology Network Partner to Streamline Cancer Care [Yahoo! Finance]
Low
Report
Evolent Health, American Oncology Network Partner to Streamline Cancer Care [Yahoo! Finance]
11/17
12:37 pm
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $13.00 to $7.00. They now have an "overweight" rating on the stock.
Medium
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $13.00 to $7.00. They now have an "overweight" rating on the stock.
11/14
03:26 pm
evh
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves [Seeking Alpha]
Low
Report
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves [Seeking Alpha]
11/13
02:25 pm
evh
MiBA Expands Support for Value-Based Cancer Care Through Partnership with American Oncology Network [Yahoo! Finance]
Low
Report
MiBA Expands Support for Value-Based Cancer Care Through Partnership with American Oncology Network [Yahoo! Finance]
11/13
09:52 am
evh
Evolent Health (NYSE:EVH) was upgraded by analysts at Stephens from an "equal weight" rating to an "overweight" rating. They now have a $7.00 price target on the stock.
Medium
Report
Evolent Health (NYSE:EVH) was upgraded by analysts at Stephens from an "equal weight" rating to an "overweight" rating. They now have a $7.00 price target on the stock.
11/13
08:11 am
evh
Evolent Health (NYSE:EVH) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $7.00 price target on the stock.
Medium
Report
Evolent Health (NYSE:EVH) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $7.00 price target on the stock.
11/12
03:35 pm
evh
Why Evolent Health (EVH) Shares Are Sliding Today [Yahoo! Finance]
Low
Report
Why Evolent Health (EVH) Shares Are Sliding Today [Yahoo! Finance]
11/12
11:30 am
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $18.00 to $12.00. They now have an "outperform" rating on the stock.
Medium
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $18.00 to $12.00. They now have an "outperform" rating on the stock.
11/12
06:43 am
evh
Evolent Health (NYSE:EVH) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
High
Report
Evolent Health (NYSE:EVH) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/11
10:27 pm
evh
Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
High
Report
Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/10
12:06 pm
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Truist Financial Corporation from $16.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Truist Financial Corporation from $16.00 to $10.00. They now have a "buy" rating on the stock.
11/10
08:44 am
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citizens Jmp from $13.00 to $11.00. They now have a "market outperform" rating on the stock.
Medium
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citizens Jmp from $13.00 to $11.00. They now have a "market outperform" rating on the stock.
11/8
02:43 pm
evh
EVH Q3 Deep Dive: Contract Wins and Industry Uncertainty Shape Outlook [Yahoo! Finance]
Medium
Report
EVH Q3 Deep Dive: Contract Wins and Industry Uncertainty Shape Outlook [Yahoo! Finance]
11/7
03:01 pm
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at BTIG Research from $20.00 to $16.00. They now have a "buy" rating on the stock.
Medium
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at BTIG Research from $20.00 to $16.00. They now have a "buy" rating on the stock.
11/7
12:40 am
evh
Evolent Health Inc (EVH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ... [Yahoo! Finance]
Low
Report
Evolent Health Inc (EVH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ... [Yahoo! Finance]
11/6
05:28 pm
evh
Evolent Health (NYSE:EVH) Beats Q3 Sales Expectations, Stock Jumps 14.8% [Yahoo! Finance]
Low
Report
Evolent Health (NYSE:EVH) Beats Q3 Sales Expectations, Stock Jumps 14.8% [Yahoo! Finance]
11/6
04:12 pm
evh
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
High
Report
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
11/6
04:10 pm
evh
Evolent Announces Third Quarter 2025 Results
High
Report
Evolent Announces Third Quarter 2025 Results
11/4
10:27 pm
evh
Evolent Health (EVH) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
Medium
Report
Evolent Health (EVH) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
10/14
07:57 am
evh
Evolent Health (NYSE:EVH) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Evolent Health (NYSE:EVH) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
10/9
08:30 am
evh
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Low
Report
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
10/3
08:10 pm
evh
Evaluating Evolent Health (EVH): Is the Recent Decline a Sign of Undervaluation? [Yahoo! Finance]
Low
Report
Evaluating Evolent Health (EVH): Is the Recent Decline a Sign of Undervaluation? [Yahoo! Finance]